Bank of New York Mellon Corp - NEVRO CORP ownership

NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 16 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NEVRO CORP
ValueSharesWeighting
Q1 2021$880,000
-54.1%
550,000
-47.6%
0.00%
Q4 2020$1,916,000
+21.6%
1,050,0000.0%0.00%
Q3 2020$1,576,000
+13.1%
1,050,0000.0%0.00%
Q2 2020$1,393,000
+8.2%
1,050,000
-0.8%
0.00%
Q1 2020$1,287,000
-10.1%
1,059,0000.0%0.00%
Q4 2019$1,432,000
+18.8%
1,059,0000.0%0.00%
Q3 2019$1,205,000
+8.7%
1,059,0000.0%0.00%
Q2 2019$1,109,000
+4.1%
1,059,0000.0%0.00%
Q1 2019$1,065,000
+224.7%
1,059,000
+202.6%
0.00%
Q4 2018$328,000
-52.9%
350,000
-50.0%
0.00%
Q3 2018$696,000
-7.7%
700,0000.0%0.00%
Q2 2018$754,000
-7.5%
700,000
-1.0%
0.00%
Q1 2018$815,000
+9.8%
707,0000.0%0.00%
Q4 2017$742,000
-9.5%
707,000
+1.0%
0.00%
Q3 2017$820,000
+121.0%
700,000
+100.0%
0.00%
Q2 2017$371,000
-12.7%
350,0000.0%0.00%
Q1 2017$425,000
-33.9%
350,000
-41.7%
0.00%
Q4 2016$643,000600,0000.00%
Other shareholders
NEVRO CORP shareholders Q3 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 27,600,000$33,560,0001.29%
OAKTREE CAPITAL MANAGEMENT LP 27,840,000$33,841,0000.49%
Nicholas Investment Partners, LP 5,530,000$6,692,0000.47%
WOLVERINE ASSET MANAGEMENT LLC 22,625,000$27,455,0000.43%
ADVENT CAPITAL MANAGEMENT /DE/ 15,650,000$19,064,0000.36%
CAMDEN ASSET MANAGEMENT L P /CA 9,275,000$11,223,0000.29%
LINDEN ADVISORS LP 1,751,000$2,130,0000.08%
LORD, ABBETT & CO. LLC 14,387,000$17,480,0000.05%
AVIVA PLC 4,500,000$5,468,0000.03%
Allianz Asset Management GmbH 24,995,000$30,481,0000.03%
View complete list of NEVRO CORP shareholders